A possible case of recipient anti-neutrophil and anti-human leukocyte antigen antibody-mediated fatal reverse transfusion-related acute lung injury
- PMID: 33666248
- DOI: 10.1111/trf.16330
A possible case of recipient anti-neutrophil and anti-human leukocyte antigen antibody-mediated fatal reverse transfusion-related acute lung injury
Abstract
Background: Transfusion-related acute lung injury (TRALI) is a transfusion complication often mediated by recipient exposure to plasma from donors with human leukocyte antigen (HLA) and human neutrophil antigen (HNA) antibodies. Recipient anti-donor HLA or HNA antibodies have rarely been implicated.
Study design and methods: Herein, we describe a case of fatal TRALI mediated by recipient anti-HLA and anti-HNA antibodies. Cognate antibody-antigen match was confirmed with serologic and molecular assays.
Results: A 69-year-old G5P5 female with no prior transfusion history and metastatic cholangiocarcinoma with thromboembolic complications presented with heart failure and dyspnea. She was transfused 15 ml of a unit of Fya -negative red blood cells and subsequently developed acute onset dyspnea, hypoxemia, hypotension, and fever. Clinical investigations revealed bilateral infiltrates on chest X-ray and cognate recipient HLA and HNA antibodies to donor antigens. The patient died of acute respiratory failure within 24 h of transfusion. In total, the patient had Fya , HLA Class I, HNA, and human platelet antigen (HPA) alloantibodies. The 63-year-old female donor had detectable HLA class II antibodies (recipient class II genotype unavailable).
Conclusion: The pathophysiology of TRALI has traditionally been ascribed to underlying conditions that put the recipient at risk in combination with donor biological response modifiers. This case illustrates alternative pathogenic mediators including alloantibodies to donor HLA and HNA. Additional studies to determine the contribution and frequency of recipient alloantibodies in TRALI may inform future mitigation strategies to further reduce the incidence of TRALI, particularly in female transfusion recipients.
Keywords: HLA; HNA; RBC; TRALI; human neutrophil antibody; red blood cell.
© 2021 AABB.
Similar articles
-
Are we underestimating reverse TRALI?Transfusion. 2019 Sep;59(9):2788-2793. doi: 10.1111/trf.15431. Epub 2019 Jun 26. Transfusion. 2019. PMID: 31241780
-
Implementation and outcomes of a transfusion-related acute lung injury surveillance programme and study of HLA/HNA alloimmunisation in blood donors.Blood Transfus. 2012 Jul;10(3):351-9. doi: 10.2450/2012.0089-11. Epub 2012 Feb 22. Blood Transfus. 2012. PMID: 22395353 Free PMC article.
-
Two cases of transfusion-related acute lung injury triggered by HLA and anti-HLA antibody reaction.J Korean Med Sci. 2010 Sep;25(9):1398-403. doi: 10.3346/jkms.2010.25.9.1398. Epub 2010 Aug 12. J Korean Med Sci. 2010. PMID: 20808691 Free PMC article.
-
Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies.Crit Care Med. 2006 May;34(5 Suppl):S118-23. doi: 10.1097/01.CCM.0000214293.72918.D8. Crit Care Med. 2006. PMID: 16617255 Review.
-
[TRALI is an overlooked severe complication related to blood transfusion].Ugeskr Laeger. 2014 Mar 31;176(7):V02130102. Ugeskr Laeger. 2014. PMID: 25096345 Review. Danish.
Cited by
-
Understanding transfusion-related acute lung injury (TRALI) and its complex pathophysiology.Blood Transfus. 2022 Nov;20(6):443-445. doi: 10.2450/2022.0232-22. Blood Transfus. 2022. PMID: 36469408 Free PMC article. No abstract available.
-
Transfusion-related Acute Lung Injury: 36 Years of Progress (1985-2021).Ann Am Thorac Soc. 2022 May;19(5):705-712. doi: 10.1513/AnnalsATS.202108-963CME. Ann Am Thorac Soc. 2022. PMID: 35045272 Free PMC article. Clinical Trial.
-
Reported transfusion-related acute lung injury associated with solvent/detergent plasma - A case series.Transfusion. 2022 Mar;62(3):594-599. doi: 10.1111/trf.16822. Epub 2022 Feb 17. Transfusion. 2022. PMID: 35174882 Free PMC article.
-
Clinical Factors of Blood Transfusion-Related Acute Lung Injury and Changes in Levels of Treg-Related Cytokines.Emerg Med Int. 2022 May 27;2022:7344375. doi: 10.1155/2022/7344375. eCollection 2022. Emerg Med Int. 2022. Retraction in: Emerg Med Int. 2024 Jan 24;2024:9796183. doi: 10.1155/2024/9796183. PMID: 35669166 Free PMC article. Retracted.
-
Transfusion-Related Acute Lung Injury: from Mechanistic Insights to Therapeutic Strategies.Adv Sci (Weinh). 2025 Mar;12(11):e2413364. doi: 10.1002/advs.202413364. Epub 2025 Jan 21. Adv Sci (Weinh). 2025. PMID: 39836498 Free PMC article. Review.
References
REFERENCES
-
- Vlaar APJ, Toy P, Fung M, Looney MR, Juffermans NP, Bux J, et al. A consensus redefinition of transfusion-related acute lung injury. Transfusion. 2019;59(7):2465-76.
-
- Kleinman S, Caulfield T, Chan P, Davenport R, McFarland J, McPhedran S, et al. Toward an understanding of transfusion-related acute lung injury: Statement of a consensus panel. Transfusion. 2004;44(12):1774-89.
-
- Popovsky MA. Transfusion-related acute lung injury: Incidence, pathogenesis and the role of multicomponent apheresis in its prevention. Transfus Med Hemother. 2008;35(2):76-9.
-
- Toy P, Gajic O, Bacchetti P, Looney MR, Gropper MA, Hubmayr R, et al. Transfusion-related acute lung injury: Incidence and risk factors. Blood. 2012;119(7):1757-67.
-
- Blumberg N, Sime PJ, Phipps RP. The mystery of transfusion-related acute lung injury. Transfusion. 2011;51(10):2054-7.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials